Colin Murdoch, president of Isomorphic Labs and Ron Alfa, CEO and co-founder of Noetik, join Washington Post Live to discuss the future of diagnostics, precision medicine, the Trump administration's recent cuts to cancer research and the evolution of cancer care. Conversation recorded on Wednesday, September 17, 2025. Program sponsored by Pfizer
From "Washington Post Live"
Listen on your iPhone
Download our iOS app and listen to interviews anywhere. Enjoy all of the listener functions in one slick package. Why not give it a try?
Comments
Add comment Feedback